Press release
US Vaccines Market worth US$38.44 billion by 2029 with 8.2% CAGR
US vaccines market (excluding COVID-19 vaccines) is segmented into recombinant vaccines, conjugate vaccines, live attenuated vaccines, toxoid vaccines, inactivated & subunit vaccines, and other vaccine technologies.
The US Vaccines Market [https://www.marketsandmarkets.com/PressReleases/us-vaccines-market.asp?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=usvaccinesmarket], (excluding COVID-19 vaccines), valued at US$25.98 billion in 2024, is forecasted to grow at a robust CAGR of 8.2%, reaching an impressive US$38.44 billion by 2029.The growth in the US vaccines market is fueled by various factors such as launch of RSV vaccines, increasing investments by government and non-government organizations for vaccine development and increasing R&D investments by market players.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1155 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1155&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=USvaccinesmarket]
Browse in-depth TOC on "US Vaccines Market"
151 - Tables
57 - Figures
By Based on technology, the US vaccines market (excluding COVID-19 vaccines) is segmented into recombinant vaccines, conjugate vaccines, live attenuated vaccines, toxoid vaccines, inactivated & subunit vaccines, and other vaccine technologies. In 2023, conjugate vaccine segment dominated the US vaccine market. Rising awareness and preventive healthcare initiatives, increasing pediatric immunization programs, and favorable government & regulatory environments have further bolstered the prominence of conjugated vaccines.
By Based on disease indication, the US vaccines market (excluding COVID-19 vaccines) is segmented into, influenza, combination vaccines, pneumococcal disease, HPV, meningococcal disease, herpes zoster, rotavirus, MMR, varicella, hepatitis, DTP, polio, RSV and other disease indications. RSV vaccine segment is likely to grow at faster CAGR during the forecast period of 2024-2029. Growing investments in vaccine R&D and novel technologies coupled with high disease burden among infants and older adults has fueled demand for RSV vaccines.
By Based on type, the US vaccines market (excluding COVID-19 vaccines) is segmented into monovalent and multivalent vaccines. Multivalent vaccines segment is likely to grow at faster CAGR during the forecast period of 2024-2029. Advancements in recombinant and conjugate vaccine technologies and increased investment by pharmaceutical companies in R&D for next-generation multivalent vaccines has fueled demand for multivalent vaccines.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=1155 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=1155&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=USvaccinesmarket]
The US vaccines market is consolidated, with a small number of players competing for market share. Merck & Co., Inc (US) Pfizer Inc. (US), Emergent (US), Johnson & Johnson Services, Inc (US), Novavax, Inc. (US), Inovio Pharmaceuticals (US), VBI Vaccines (US) and among others are some of the leading players in this market. Most companies in the market focus on organic and inorganic growth strategies, such as product launches, expansions, acquisitions, partnerships, agreements, and collaborations, to increase their product offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the US market.
Study Coverage:
The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the US vaccines market. The market also covers the impact of the recession. A detailed analysis of the key industry players has been done to provide insights into their business overviews; key strategies; acquisitions, new product launches, expansions, agreements, and recent developments associated with the US vaccines market.
For more information, Inquire Now! [https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=1155&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=USvaccinesmarket]
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=us-vaccines-market-worth-us3844-billion-by-2029-with-82-cagr]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/PressReleases/us-vaccines-market.asp
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Vaccines Market worth US$38.44 billion by 2029 with 8.2% CAGR here
News-ID: 3972372 • Views: …
More Releases from ABNewswire
Limitless Lifestyle Founder Cymron Bancil Named Best Executive Health Coach in U …
USA - Cymron Bancil's reputation as the best executive health coach in the USA wasn't built on trends or personality. It was earned through precision. His journey from hedge fund boardrooms to coaching elite leaders began not in a gym, but inside the world of global finance, where every decision carried weight and systems ruled outcomes.
Image: https://www.abnewswire.com/upload/2026/02/29ce9791dc29cc0df66053555e10400f.jpg
With over 15 years in investment banking and asset management, Bancil led teams at…
Yanik Guillemette: Securing Resilient Trade Amid CUSMA Challenges
As trade uncertainties rise, Quebec entrepreneur Yanik Guillemette emphasizes strategic diversification and robust protection for Canadian exports to ensure long-term stability.
Image: https://cdn.shopify.com/s/files/1/0719/9090/3064/files/Yanik_Guillemette_Quebec_Entrepreneur.jpg?v=1769600497
MONTREAL, Quebec - Feb 6, 2026 - The Canadian trade landscape is entering a period of significant recalibration. With the impending review of the Canada-United States-Mexico Agreement (CUSMA/USMCA) and the looming threat of cross-border tariffs, the nation's export-driven economy faces a critical test. Amidst this volatility, Yanik Guillemette [https://www.yanikguillemette.com/],…
UHN Plus Launches 'How Do They Vote?' / '?Como votan?' - Free Bilingual Tool To …
UHN Plus launched "How Do They Vote?" (English) and "?Como votan?" (Spanish), a free bilingual platform to track congressional votes. The tool allows users to enter their ZIP code to see their representatives and their voting records on key issues. The platform aims to provide accessible, non-partisan information to empower voters ahead of the 2026 midterm elections.
UHN Plus, a leading digital media platform delivering real-time news and civic tools to…
Fertily.org launches an email-based fertility guidance service to help families …
Fertily.org has launched an email-based fertility guidance service that provides personalized, human support to individuals and couples navigating fertility treatment decisions. Through direct email correspondence with an experienced fertility coordinator, patients receive clear explanations of treatment options, cost guidance, clinic recommendations, and ongoing support.
Saint-Sauveur, Canada - February 6, 2026 - Fertily.org has officially launched as a personalized, email-correspondence fertility support service designed to help individuals and couples navigate the complexity…
More Releases for Johnson
Sarcoma Treatment Market Is Booming Worldwide 2025-2032 | Amgen Inc., Johnson & …
Coherent Market Insights has released a statistical report titled "Sarcoma Treatment Market Recent Trends, In-depth Analysis, Size, and Forecast 2025-2032." This report offers a comprehensive overview of the competitive landscape, geographical segmentation, innovation, future developments, and a compilation of tables and data. The competitive landscape analysis provides detailed information about each vendor, encompassing company profiles, total revenue (financials), market potential, presence, market share, pricing, locations of production facilities, and the…
Artificial Limbs and Joints Market Expected to reach a Hugh Growth by 2031 | Art …
Artificial Limbs and Joints Market is the focal point of DataM Intelligence's latest market research report, offering a comprehensive analysis of this dynamic sector. This in-depth study goes beyond a basic overview, exploring the intricate dynamics that shape the market. By examining regional trends, demand patterns, and potential breakthroughs, DataM Intelligence aims to empower businesses and stakeholders with valuable insights for navigating the evolving landscape. The insights from this report…
Artificial Limbs and Joints Industry to Witness Massive Growth (2024-2031) | Art …
Artificial Limbs and Joints Industry Analysis, according DataM Intelligence. Although data provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.
Will the Artificial Limbs and Joints market emerge as the sector's next great thing? To discover the answer, look at the Artificial Limbs and…
Wet Tissues and Wipes Market Shaping from Growth to Value: 3M, Johnson & Johnson …
The Latest Released Wet Tissues and Wipes market study has evaluated the growth forecast and potential of Global Wet Tissues and Wipes market to provide information and useful stats on market value and size. The study is framed to provide market intelligence and strategic insights to help decision-makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, and emerging…
Biotechnology Market - Development Outlook 2025 | Pfizer, Johnson & Johnson
Global Biotechnology Market: Overview
The global biotechnology market is mainly driven by the surge in the demand for food, depleting natural resources, government regulatory support, and technological advancements of various solutions to counter fatal diseases. The advent of stem cell technology, nanotechnology, and cloning has also propelled this market substantially and is expected to continue aiding to this market in the years to come. However, the dearth of awareness among consumers…
Global Facial Wipes Sales Market 2017 - Beiersdorf, Johnson & Johnson, SC Johnso …
The Global Facial Wipes Sales Industry report gives a comprehensive account of the Global Facial Wipes Sales market. Details such as the size, key players, segmentation, SWOT analysis, most influential trends, and business environment of the market are mentioned in this report. The report features an up-to-date data on key companies product details, revenue figures, and sales. The business model strategies of the key firms in the Facial Wipes Sales…
